FOR RESEARCH USE ONLY
Clinical trial literatureWellness research

Glutathione

Master endogenous tripeptide antioxidant researched for oxidative stress, detoxification, immune support and skin brightening.

01Redox balance02Phase II metabolism03Melanin pathways
Molecular signature / glutathione
Structural identity

Endogenous tripeptide antioxidant containing a gamma-peptide linkage

Also known as

Reduced glutathione · GSH · γ-L-glutamyl-L-cysteinylglycine

Research-use context

In-vitro and laboratory information only. No human-use recommendation.

Guide contentsOpen in calculator
Section 01

Compound briefing

Glutathione (γ-Glu-Cys-Gly) is the body's principal intracellular antioxidant and a critical cofactor for detoxification enzymes. It is studied for reducing oxidative stress, supporting liver function, modulating immune responses, and as an adjunctive skin-brightening agent through melanin-inhibiting mechanisms.

The research question

Glutathione participates directly in redox reactions and serves as a substrate for several detoxification enzymes. Research should measure defined oxidative, hepatic or melanin-related endpoints rather than relying on the broad label of master antioxidant.

Section 02

Mechanism & research themes

Directly neutralises reactive oxygen species and regenerates other antioxidants (vitamins C and E). Serves as a substrate for glutathione peroxidase and glutathione S-transferase enzymes involved in phase II detoxification. In melanocytes, reduced glutathione shifts melanin production from eumelanin toward phaeomelanin.

01

Master antioxidant activity across multiple cellular compartments

02

Phase II detoxification support and xenobiotic clearance

03

Immune-cell function and inflammatory balance modulation

04

Skin-brightening and melanin-modulating effects in research

05

Liver and mitochondrial protection under oxidative challenge

06

Replenishes levels depleted by ageing, stress and environmental toxins

These are research themes reported across the literature, not established benefits or indications.

Section 03

Evidence assessment

Clinical trial literature

Its biochemical role is well established, but outcomes depend strongly on route, formulation and endpoint. Antioxidant capacity alone does not validate skin, detoxification or disease-treatment claims.

What to look for

Controlled design, a defined preparation, clinically relevant endpoints and independent replication carry more weight than a single mechanism study.

What not to assume

A plausible pathway does not establish efficacy. Results across different routes, formulations and populations are not automatically interchangeable.

Section 04

Protocol literature

Commonly referenced research protocols use 200–600mg subcutaneously or intramuscularly per session, 1–3× weekly, or 600–1500mg weekly in divided doses. Skin-brightening research often uses higher-dose IV protocols under clinical supervision. Cycles typically run 4–12 weeks.

Reported persistence

Plasma half-life is short (minutes); intracellular pools replenish over hours to days with repeated dosing.

Calculator starting point

200 mg per reference dose

3 doses per week · 8-week cycle

5 mL default reconstitution volume

200–600 mg SC/IM 1–3×/week; protect from light after reconstitution.

Calculator defaults are editable mathematical reference values, not dosing advice. Verify all calculations independently.

Calculate Glutathione
Section 05

Laboratory handling

Reconstitution reference

Reconstitute a 600mg vial with 3–6mL bacteriostatic water for a 100–200mg/mL concentration. For 1500mg vials, 5–10mL is typical. Swirl gently — do not shake.

Storage reference

Lyophilised: 2–8°C, stable 12–18 months. Reconstituted: 2–8°C, protect from light, use within 14–21 days due to oxidation sensitivity.

Minimum documentation standard

  • Record the lot identifier and review its matching analytical documentation.
  • Use aseptic technique and record diluent, final volume and calculated concentration.
  • Label preparation date, storage conditions and any light or freeze–thaw restrictions.
  • Inspect before each use and investigate unexpected colour, clarity or particulate changes.
Section 06

Limitations & safety

L1

Injectable and IV glutathione can cause sulphur-like taste or odour shortly after administration.

L2

Asthma exacerbation has been reported in susceptible individuals.

L3

Reconstituted glutathione oxidises over time; use promptly and protect from light.

Research use only

This field note is an educational literature summary, not medical advice or a recommendation for human use. Safety statements are limited by the quality and duration of the available evidence.

Continue reading

Related field notes

Back to all field notes

Welcome to HV Labs

Please confirm your age to continue.

For research use only